FindTrial
Sign In

Prevalence of Monoclonal Gammopathy of Undetermined Significance in Tamil Nadu, India: A Population-based Prospective Cohort Study

MGUS Epidemiology Study in India - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/03/064362
Enrollment
4100
Registered
2024-03-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Cancer Institute WIA Adyar Chennai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The participants will be included in the study after giving a signed written informed consent.

Exclusion criteria

Exclusion criteria: -Previous history of lymphoproliferative disorders such as Waldenström macroglobulinemia or chronic lymphocytic leukemia -Non consent

Design outcomes

Primary

MeasureTime frame
To estimate the prevalence of MGUS in the communityTimepoint: 3 years—

Secondary

MeasureTime frame
•To identify epidemiological factors related to MGUS •To validate MALDI-TOF mass spectrometry for M-protein analysis by the acetonitrile precipitation technique Timepoint: 3 years—

Countries

India

Contacts

Public ContactMs Subhiksha Sundaram

Cancer Institute WIA Adyar

m.nikita@cancerinstitutewia.org04422209150

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026